Literature DB >> 24219114

Extracellular matrix and liver disease.

Elena Arriazu1, Marina Ruiz de Galarreta, Francisco Javier Cubero, Marta Varela-Rey, María Pilar Pérez de Obanos, Tung Ming Leung, Aritz Lopategi, Aitor Benedicto, Ioana Abraham-Enachescu, Natalia Nieto.   

Abstract

SIGNIFICANCE: The extracellular matrix (ECM) is a dynamic microenvironment that undergoes continuous remodeling, particularly during injury and wound healing. Chronic liver injury of many different etiologies such as viral hepatitis, alcohol abuse, drug-induced liver injury, obesity and insulin resistance, metabolic disorders, and autoimmune disease is characterized by excessive deposition of ECM proteins in response to persistent liver damage. CRITICAL ISSUES: This review describes the main collagenous and noncollagenous components from the ECM that play a significant role in pathological matrix deposition during liver disease. We define how increased myofibroblasts (MF) from different origins are at the forefront of liver fibrosis and how liver cell-specific regulation of the complex scarring process occurs. RECENT ADVANCES: Particular attention is paid to the role of cytokines, growth factors, reactive oxygen species, and newly identified matricellular proteins in the regulation of fibrillar type I collagen, a field to which our laboratory has significantly contributed over the years. We compile data from recent literature on the potential mechanisms driving fibrosis resolution such as MF' apoptosis, senescence, and reversal to quiescence. FUTURE DIRECTIONS: We conclude with a brief description of how epigenetics, an evolving field, can regulate the behavior of MF and of how new "omics" tools may advance our understanding of the mechanisms by which the fibrogenic response to liver injury occurs.

Entities:  

Mesh:

Year:  2014        PMID: 24219114      PMCID: PMC4123471          DOI: 10.1089/ars.2013.5697

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  162 in total

Review 1.  The extracellular matrix: an active or passive player in fibrosis?

Authors:  Thomas N Wight; Susan Potter-Perigo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-21       Impact factor: 4.052

Review 2.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

3.  Epigenetics: reversing the 'irreversible'.

Authors:  Richard S Jones
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

4.  NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.

Authors:  Andreas Glässner; Marianne Eisenhardt; Benjamin Krämer; Christian Körner; Martin Coenen; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

Review 5.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

6.  Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.

Authors:  Claudia Mitchell; Dominique Couton; Jean-Pierre Couty; Marie Anson; Anne-Marie Crain; Vinciane Bizet; Laurent Rénia; Stanislas Pol; Vincent Mallet; Hélène Gilgenkrantz
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

7.  Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms.

Authors:  Francisco Javier Cubero; Natalia Nieto
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

8.  Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models.

Authors:  Simon Rogers; Mark Girolami; Walter Kolch; Katrina M Waters; Tao Liu; Brian Thrall; H Steven Wiley
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

9.  Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis.

Authors:  Yuki Kita; Toshinari Takamura; Hirofumi Misu; Tsuguhito Ota; Seiichiro Kurita; Yumie Takeshita; Masafumi Uno; Naoto Matsuzawa-Nagata; Ken-Ichiro Kato; Hitoshi Ando; Akio Fujimura; Koji Hayashi; Toru Kimura; Yinhua Ni; Toshiki Otoda; Ken-ichi Miyamoto; Yoh Zen; Yasuni Nakanuma; Shuichi Kaneko
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 10.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more
  36 in total

1.  Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis.

Authors:  Archana Rastogi; Nayana Patil; Rakhi Maiwall; Chhagan Bihari; Ananda Soshee; Shiv K Sarin
Journal:  Virchows Arch       Date:  2021-04-02       Impact factor: 4.064

Review 2.  Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment.

Authors:  Mariia Zadorozhna; Sante Di Gioia; Massimo Conese; Domenica Mangieri
Journal:  Mol Biol Rep       Date:  2020-02-10       Impact factor: 2.316

3.  Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin.

Authors:  Philippe Lefebvre; Fanny Lalloyer; Eric Baugé; Michal Pawlak; Céline Gheeraert; Hélène Dehondt; Jonathan Vanhoutte; Eloise Woitrain; Nathalie Hennuyer; Claire Mazuy; Marie Bobowski-Gérard; Francesco Paolo Zummo; Bruno Derudas; Ann Driessen; Guy Hubens; Luisa Vonghia; Wilhelmus J Kwanten; Peter Michielsen; Thomas Vanwolleghem; Jérôme Eeckhoute; An Verrijken; Luc Van Gaal; Sven Francque; Bart Staels
Journal:  JCI Insight       Date:  2017-07-06

4.  Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet-fed rats.

Authors:  Fariha Kabir; Kamrun Nahar; Md Mizanur Rahman; Fariha Mamun; Shoumen Lasker; Ferdous Khan; Tahmina Yasmin; Khondker Ayesha Akter; Nusrat Subhan; Md Ashraful Alam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-08-11       Impact factor: 3.000

5.  Myofibroblast-specific YY1 promotes liver fibrosis.

Authors:  Huan Liu; Shuya Zhang; Suowen Xu; Marina Koroleva; Eric M Small; Zheng Gen Jin
Journal:  Biochem Biophys Res Commun       Date:  2019-05-10       Impact factor: 3.575

6.  Genetic Background is a Key Determinant of Glomerular Extracellular Matrix Composition and Organization.

Authors:  Michael J Randles; Adrian S Woolf; Jennifer L Huang; Adam Byron; Jonathan D Humphries; Karen L Price; Maria Kolatsi-Joannou; Sophie Collinson; Thomas Denny; David Knight; Aleksandr Mironov; Toby Starborg; Ron Korstanje; Martin J Humphries; David A Long; Rachel Lennon
Journal:  J Am Soc Nephrol       Date:  2015-04-20       Impact factor: 10.121

7.  Liver donor age affects hepatocyte function through age-dependent changes in decellularized liver matrix.

Authors:  Aylin Acun; Ruben Oganesyan; Korkut Uygun; Heidi Yeh; Martin L Yarmush; Basak E Uygun
Journal:  Biomaterials       Date:  2021-01-21       Impact factor: 12.479

Review 8.  It's all about the spaces between cells: role of extracellular matrix in liver fibrosis.

Authors:  Amit Khurana; Nilofer Sayed; Prince Allawadhi; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2021-04

9.  Elucidating Extracellular Matrix and Stiffness Control of Primary Human Hepatocyte Phenotype Via Cell Microarrays.

Authors:  Chase P Monckton; Aidan Brougham-Cook; Kerim B Kaylan; Gregory H Underhill; Salman R Khetani
Journal:  Adv Mater Interfaces       Date:  2021-10-22       Impact factor: 6.147

Review 10.  Diet-Regulating Microbiota and Host Immune System in Liver Disease.

Authors:  Jung A Eom; Goo Hyun Kwon; Na Yeon Kim; Eun Ju Park; Sung Min Won; Jin Ju Jeong; Ganesan Raja; Haripriya Gupta; Yoseph Asmelash Gebru; Satyapriya Sharma; Ye Rin Choi; Hyeong Seop Kim; Sang Jun Yoon; Ji Ye Hyun; Min Kyo Jeong; Hee Jin Park; Byeong Hyun Min; Mi Ran Choi; Dong Joon Kim; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.